RCUS logo

Arcus Biosciences, Inc. (RCUS)

Profile

Full Name

Arcus Biosciences, Inc.

Ticker

NYSE: RCUS

Exchange

NYSE

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

March 15, 2018

Indexes

Not included

Website

https://www.arcusbio.com

Employees

627

Key Details

Price

$11.52(+0.17%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$258.00M(+120.51% YoY)

Annual EPS

-$3.14(+24.34% YoY)

PE ratio

-

Next earnings date

Nov 6, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $11.52
    RCUS price is $11.52

    30-Day Relative Volume

    0.77
    RCUS 30-day relative volume is 0.77

    Price Performance

    Price Most recent change

    +0.17%
    RCUS price was up +0.17% on Sep 12, 2025

    Price YTD change

    -22.63%
    RCUS price is down -22.63% since January 1st

    Price 1-year change

    -33.76%
    RCUS price is down -33.76% year-on-year

    Price 3-year change

    -55.3%
    RCUS price is down -55.3% over the past 3 years

    Price Range

    Price All-time high

    $49.10
    RCUS price is currently -76.54% below its historical high of $49.10

    Price 3-year low

    $6.50
    RCUS price is currently +77.23% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $1.23B
    RCUS market capitalization is $1.23 billion

    Market cap 3-year change

    -34.07%
    RCUS market capitalization is down -34.07% over the past 3 years

    Market cap All-time high

    $3.40B
    RCUS market capitalization is currently -63.99% below its historical high of $3.40 billion

    Market cap sector rank

    75.38%
    RCUS market capitalization is higher than 75.38% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +16.41%
    RCUS shares outstanding is up +16.41% year-on-year

    Shares Outstanding 3-Year Change

    +47.49%
    RCUS shares outstanding is up +47.49% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.29
    RCUS beta is 1.29

    200-day SMA

    $10.79
    RCUS price is currently +6.73% above its 200-day simple moving average

    50-day SMA

    $9.98
    RCUS price is currently +15.48% above its 50-day simple moving average

    RSI

    61.02
    RCUS 14-day relative strength index is 61.02

    Volume

    0.77
    RCUS 30-day relative volume is 0.77

    ATR

    $0.57
    RCUS average true range is $0.57

    10-day Historical Volatility

    62.70%
    RCUS 10-day historical volatility is 62.70%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $258.00M
    RCUS annual revenue is $258.00 million

    Revenue Analysts estimate

    $228.93M
    RCUS annual revenue is currently +12.70% higher than the consensus analysts' forecast

    Revenue 1-year change

    +120.51%
    RCUS annual revenue is up +120.51% year-on-year

    Revenue Sector rank

    76.08%
    RCUS annual revenue is higher than 76.08% of companies in Healthcare sector

    EPS

    EPS

    -$3.14
    RCUS annual earnings per share is -$3.14

    EPS Analysts estimate

    -$3.71
    RCUS annual earnings per share is currently -15.32% lower than the consensus analysts' forecast

    EPS 1-year change

    +24.34%
    RCUS annual earnings per share is up +24.34% year-on-year

    EPS Sector rank

    27.61%
    RCUS annual earnings per share is higher than 27.61% of companies in Healthcare sector

    Profit

    Gross profit

    $248.00M
    RCUS annual gross profit is $248.00 million

    Gross margin

    96.12%
    RCUS annual gross profit margin is 96.12%

    Operating profit

    -$310.00M
    RCUS annual operating income is -$310.00 million

    Operating margin

    -120.16%
    RCUS annual operating profit margin is -120.16%

    Net income

    -$283.00M
    RCUS annual net profit is -$283.00 million

    Net margin

    -109.69%
    RCUS annual net profit margin is -109.69%

    Expenses

    Total expenses

    $568.00M
    RCUS annual total expenses is $568.00 million

    Operating expenses

    $568.00M
    RCUS annual total operating expenses is $568.00 million

    Cost of goods sold

    $10.00M
    RCUS annual cost of goods sold is $10.00 million

    Selling, general & administrative expenses

    $120.00M
    RCUS annual SGA is $120.00 million

    Depreciation and amortization

    $10.00M
    RCUS annual depreciation & amortization is $10.00 million

    Interest expense

    $0.00
    RCUS annual interest expense is $0.00

    Income tax

    $1.00M
    RCUS annual income tax is $1.00 million

    EBIT & EBITDA

    EBIT

    -$279.00M
    RCUS annual earnings before interest & taxes is -$279.00 million

    EBITDA

    -$269.00M
    RCUS annual EBITDA is -$269.00 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $1.15B
    RCUS annual total assets is $1.15 billion

    Non current assets

    $134.00M
    RCUS annual long term assets is $134.00 million

    Current assets

    $1.02B
    RCUS annual total current assets is $1.02 billion

    Cash and cash equivalents

    $150.00M
    RCUS annual cash & cash equivalents is $150.00 million

    Accounts receivable

    $20.00M
    RCUS annual accounts receivable is $20.00 million

    Inventory

    $0.00
    RCUS annual inventory is $0.00

    Liabilities

    Total liabilities

    $665.00M
    RCUS annual total liabilities is $665.00 million

    Long term liabilities

    $439.00M
    RCUS annual total long term liabilities is $439.00 million

    Current liabilities

    $226.00M
    RCUS annual total current liabilities is $226.00 million

    Accounts payable

    $18.00M
    RCUS annual accounts payable is $18.00 million

    Debt

    Total debt

    $159.00M
    RCUS annual total debt is $159.00 million

    Total debt 1-year change

    +31.4%
    RCUS annual total debt is up +31.4% year-on-year

    Long term debt

    $147.00M
    RCUS annual long term debt is $147.00 million

    Short term debt

    $12.00M
    RCUS annual short term debt is $12.00 million

    Equity & Capital

    Shareholders equity

    $485.00M
    RCUS annual stockholders equity is $485.00 million

    Book value

    $485.00M
    RCUS annual book value is $485.00 million

    Retained earnings

    -$1.13B
    RCUS annual retained earnings is -$1.13 billion

    Working capital

    $790.00M
    RCUS annual working capital is $790.00 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$170.00M
    RCUS annual cash flow from operations is -$170.00 million

    Cash from operations 1-year change

    +44.44%
    RCUS annual cash flow from operations is up +44.44% year-on-year

    Cash from investing

    -$84.00M
    RCUS annual cash flow from investing activities is -$84.00 million

    Cash from investing 1-year change

    -143.3%
    RCUS annual cash flow from investing activities is down -143.3% year-on-year

    Cash from financing

    $277.00M
    RCUS annual cash flow from financing activities is $277.00 million

    Cash from financing 1-year change

    +739.39%
    RCUS annual cash flow from financing activities is up +739.39% year-on-year

    CAPEX

    CAPEX

    $6.00M
    RCUS annual capital expenditures is $6.00 million

    CAPEX 1-year change

    -75%
    RCUS annual capital expenditures is down -75% year-on-year

    Free Cash Flow

    Free cash flow

    -$176.00M
    RCUS annual free cash flow is -$176.00 million

    Free cash flow 1-year change

    +46.67%
    RCUS annual free cash flow is up +46.67% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    96.12%
    RCUS annual gross profit margin is 96.12%

    Operating margin

    -120.16%
    RCUS annual operating profit margin is -120.16%

    Net margin

    -109.69%
    RCUS annual net profit margin is -109.69%

    ROA & ROE

    ROA

    -25.21%
    RCUS annual return on assets is -25.21%

    ROE

    -59.77%
    RCUS annual return on equity is -59.77%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    RCUS price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    RCUS price to earnings ratio is unknown

    PB Ratio

    PB ratio

    2.23
    RCUS price to book ratio is 2.23

    PB ratio Sector rank

    56.36%
    RCUS price to book ratio is higher than 56.36% of companies in Healthcare sector

    PS Ratio

    PS ratio

    4.68
    RCUS price to sales ratio is 4.68

    PS ratio Sector rank

    55.96%
    RCUS price to sales ratio is higher than 55.96% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $424.09M
    RCUS enterprise value is $424.09 million

    Enterprise value Sector rank

    63.74%
    RCUS enterprise value is higher than 63.74% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -1.50
    RCUS EV/EBITDA is -1.50

    EV/EBITDA Sector rank

    41.9%
    RCUS EV/EBITDA is higher than 41.9% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    4.50
    RCUS annual current ratio is 4.50

    Quick ratio

    4.50
    RCUS annual quick ratio is 4.50

    Leverage

    Debt to equity

    0.33
    RCUS annual debt to equity ratio is 0.33

    Interest coverage ratio

    -
    RCUS annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    2
    RCUS piotroski f-score is 2

    Altman Z-Score

    -0.02
    RCUS altman z-score is -0.02

    Analyst ratings

    Recent major analysts updates

    Aug 7, 25 Wells Fargo
    Overweight
    May 9, 25 Morgan Stanley
    Overweight
    May 8, 25 Goldman Sachs
    Neutral
    May 7, 25 Wells Fargo
    Overweight
    Apr 23, 25 Barclays
    Overweight
    Feb 26, 25 HC Wainwright & Co.
    Buy
    Feb 19, 25 B of A Securities
    Neutral
    Feb 18, 25 Morgan Stanley
    Overweight
    Feb 18, 25 HC Wainwright & Co.
    Neutral
    Nov 6, 24 HC Wainwright & Co.
    Neutral

    Institutional Ownership

    Screeners with RCUS included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Best performing stocks last month
    Most recommended stocks
    Best performing stocks last 3 months
    Stocks below analysts price target
    Healthcare sector
    All stocks
    Biotech Companies
    • What is the ticker symbol for Arcus Biosciences, Inc.?
    • Does Arcus Biosciences, Inc. pay dividends?
    • What sector is Arcus Biosciences, Inc. in?
    • What industry is Arcus Biosciences, Inc. in?
    • What country is Arcus Biosciences, Inc. based in?
    • When did Arcus Biosciences, Inc. go public?
    • Is Arcus Biosciences, Inc. in the S&P 500?
    • Is Arcus Biosciences, Inc. in the NASDAQ 100?
    • Is Arcus Biosciences, Inc. in the Dow Jones?
    • When was Arcus Biosciences, Inc.'s last earnings report?
    • When does Arcus Biosciences, Inc. report earnings?

    What is the ticker symbol for Arcus Biosciences, Inc.?

    The ticker symbol for Arcus Biosciences, Inc. is NYSE:RCUS

    Does Arcus Biosciences, Inc. pay dividends?

    No, Arcus Biosciences, Inc. does not pay dividends

    What sector is Arcus Biosciences, Inc. in?

    Arcus Biosciences, Inc. is in the Healthcare sector

    What industry is Arcus Biosciences, Inc. in?

    Arcus Biosciences, Inc. is in the Biotechnology industry

    What country is Arcus Biosciences, Inc. based in?

    Arcus Biosciences, Inc. is headquartered in United States

    When did Arcus Biosciences, Inc. go public?

    Arcus Biosciences, Inc.'s initial public offering (IPO) was on March 15, 2018

    Is Arcus Biosciences, Inc. in the S&P 500?

    No, Arcus Biosciences, Inc. is not included in the S&P 500 index

    Is Arcus Biosciences, Inc. in the NASDAQ 100?

    No, Arcus Biosciences, Inc. is not included in the NASDAQ 100 index

    Is Arcus Biosciences, Inc. in the Dow Jones?

    No, Arcus Biosciences, Inc. is not included in the Dow Jones index

    When was Arcus Biosciences, Inc.'s last earnings report?

    Arcus Biosciences, Inc.'s most recent earnings report was on May 7, 2025

    When does Arcus Biosciences, Inc. report earnings?

    The next expected earnings date for Arcus Biosciences, Inc. is November 6, 2025
    On this page